Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SHR

Schering Aktiengesel (SHR)

Bank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:SHR
DateTimeSourceHeadlineSymbolCompany
19/01/200719:20PR Newswire (US)Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative DiseasesNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
06/12/200600:25PR Newswire (US)Bayer Determines EUR 98.98 as Cash Compensation per Schering ShareNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
28/11/200619:45PR Newswire (US)Schering AG and Stanford University to Cooperate in the Field of Molecular ImagingASX:SHR
27/11/200618:33PR Newswire (US)Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006ASX:SHR
25/11/200604:25PR Newswire (US)NYSE Suspends Trading in Schering ADRsNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
23/11/200620:40PR Newswire (US)Betaferon(R) Approved in Australia for Earliest Stages of Multiple SclerosisASX:SHR
08/11/200617:54PR Newswire (US)Go-Ahead for Schering's Integration Into the Bayer GroupNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
01/11/200600:00PR Newswire (US)Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's LymphomaASX:SHR
31/10/200606:10PR Newswire (US)Entry in the Commercial Register - Agreement Between Bayer and Schering in Force - Resolution of Schering Extraordinary StockholNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
24/10/200600:39PR Newswire (US)FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple SclerosisASX:SHR
17/10/200623:47PR Newswire (US)Family Planning Programs in the Fight Against PovertyASX:SHR
05/10/200622:30PR Newswire (US)FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)ASX:SHR
19/09/200617:58PR Newswire (US)Schering AG and Organon to Continue Research in Male Fertility Control SeparatelyASX:SHR
19/09/200600:01PR Newswire (US)Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & LombASX:SHR
15/09/200618:32PR Newswire (US)Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer DrugASX:SHR
15/09/200600:00PR Newswire (US)MEDRAD Employees Care in a Big Way: Facilities Suspend Operations Today so That 800 Can Volunteer in CommunityASX:SHR
14/09/200622:48PR Newswire (US)Stockholders Pave the Way for Bayer Schering PharmaASX:SHR
13/09/200620:32PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG in BerlinNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
04/09/200621:19PR Newswire (US)Schering AG Completes Reconstruction Projects in Indonesia and ThailandASX:SHR
02/09/200600:00PR Newswire (US)MEDRAD Holds Job Fair To Support Company GrowthNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
30/08/200620:13PR Newswire (US)Group Environmental Report for 2006 PublishedASX:SHR
17/08/200601:50PR Newswire (US)Frost & Sullivan Lauds MEDRAD Excellent Product Innovation Abilities in the MRI Coils MarketNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
04/08/200618:15PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG on September 13, 2006: Schering's Stockholders to Resolve on Domination andASX:SHR
03/08/200600:00PR Newswire (US)New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment PlanningASX:SHR
01/08/200600:49PR Newswire (US)Berlex Voluntarily Recalls Ultravist(R) Injection 370 mgI/mLASX:SHR
01/08/200600:36PR Newswire (US)Schering AG, Germany Announces Results of Two Clinical Trials With Sargramostim in Crohn's Disease PatientsASX:SHR
01/08/200600:21PR Newswire (US)Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/mlASX:SHR
01/08/200600:20PR Newswire (US)Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) Injection 370 mgI/ml Recall and Insufficient Results of Clinical PNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
27/07/200604:46PR Newswire (US)KPMG Values Schering AG Share at EUR 87.63ASX:SHR
25/07/200617:28PR Newswire (US)Schering AG Raises Outlook After Strong First Half YearASX:SHR
 Showing the most relevant articles for your search:NYSE:SHR